Search

everythinglearnresearchcommunity

for

Search:↓

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Unregulated glucocorticoid use can disrupt hormone balance and cause serious health issues.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Metformin can help prevent the side effects of glucocorticoid medications on metabolism.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

Nanotechnology can improve tissue healing by controlling immune responses.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Retinoids may help treat lupus nephritis and reduce steroid use.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

α-MSH may help treat skin inflammation and fibrosis.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.